Figure 3.

Odds ratios for developing colorectal cancer in different MPRs for selective COX-2 inhibitors in (a) age>=65, (b) age<65, (c) males and (d) females (Note: Significant odds ratios are at (a) 10% of 5-year, 10% to 40% of 3-year, 10% to 50% of 1-year, 30% to 60% of 6-month, and 90% of 3-month; (d) 10% of 5-year, 20% to 40% of 3-year, 10% to 50% of 1-year, 40% of 6-month).

Yang et al. BMC Cancer 2012 12:582   doi:10.1186/1471-2407-12-582
Download authors' original image